Clinical Trials
3 trialsNCT02602067 2018-09-18
Tenatumomab
sigma-tau i.f.r. S.p.A.
Phase 1 Terminated
NCT01491594 2014-04-02
Eltrombopag for the Prevention of Chemotherapy Induced Thrombocytopenia
Duke University
Phase 1 Terminated
NCT00102609 2013-01-10
A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Phase 1 Completed